Engineered IL-2 molecule shows promise in treating autoimmune disease
Researchers from The Institute, in collaboration with Sanofi, develop a novel therapy to enhance immune regulation in...
D2R awards over $6 million to support Core Platforms
Three platforms at The Institute will benefit from new funding for innovation and sustainability
Ensuring everyone can fully participate in research and healthcare
The MUHC and The Institute’s accessibility plan is commended by the Office des personnes handicapées...
Fall 2024 CIHR competition results
Teams from The Institute received $18.4 million in project funding
American College of Rheumatology honours a trainee from The Institute
Leah Flatman’s research investigates risks associated with maternal medication exposure during pregnancy
Tuberculosis: A persistent threat, yet clinical trials show promise
Researchers at The Institute advance the search for preventive treatments for multidrug-resistant TB
Study links alcohol consumption to more severe nut allergy reaction
Researchers find patterns in anaphylaxis symptoms that could help people manage their health risks
Ana Copaescu receives the 2024 FMSQ Research Award
Dr. Copaescu’s influential publication in Jama Internal Medicine evaluated a safer and simpler approach to penicillin allergy testing
Canada's Top 40 Research Hospitals: number 1 in Quebec, number 3 in the country!
Thanks to the researchers, trainees and staff at The Institute, the MUHC maintains its leadership position in the...
MARVIN: the first AI-powered HIV care chatbot
When life's everyday challenges get in the way, it can be hard to stay on track with antiretroviral therapy. A new chatbot could help.